DJIA 18,094.21 64.00 0.35%
NASDAQ 4,814.41 40.93 0.86%
S&P 500 2,091.95 10.07 0.48%
market minute promo

Sanofi (ADR) (NYSE: SNY)



company name or ticker
Company Photos
(Click to zoom)

5 Critical Biotech Drug Dates and Events for December

Health Care Sector Update for 12/01/2014: IMUC,ARES,POZN,SNY

Morning Market Losers

Sanofi Rights - Is GCVRZ Underpriced Or Is The Market Efficient?

MannKind: The Newest Bear Talking Point Is Absurd

Keryx Biopharmaceuticals: 40% Upside In The Bear Case

Best Idea For 2014: Sanofi Rights Post-FDA Approval

Why A Merck Clinical Trial May Help Amgen And Regeneron Shares To Set Higher Highs

Should Gilead Sciences, Inc. Pay a Dividend?

Shares of Gilead Sciences have skyrocketed over the past two years, propelling the company into the upper echelons of the healthcare sector in terms of market cap. With all of its new peer group offering a dividend, should Gilead follow suit?

Will Insulin Pricing Be MannKind Corporation's Downfall?

MannKind marketing partner Sanofi had to discount its Lantus insulin to get insurers to cover the drug.
See More Articles...